Oxford Biomedica (LON:OXB) Shares Pass Below 200 Day Moving Average - Time to Sell?

Oxford Biomedica plc (LON:OXB - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 359.21 ($4.85) and traded as low as GBX 299 ($4.04). Oxford Biomedica shares last traded at GBX 303.50 ($4.10), with a volume of 65,557 shares trading hands.

Oxford Biomedica Trading Down 5.0%

The stock has a market cap of £331.66 million, a PE ratio of -2.32 and a beta of 1.09. The company has a current ratio of 2.35, a quick ratio of 1.67 and a debt-to-equity ratio of 166.48. The business has a 50 day moving average of GBX 291.94 and a 200-day moving average of GBX 357.31.

Oxford Biomedica (LON:OXB - Get Free Report) last issued its earnings results on Wednesday, April 9th. The biopharmaceutical company reported GBX (41.75) (($0.56)) earnings per share for the quarter. Oxford Biomedica had a negative return on equity of 202.50% and a negative net margin of 145.98%. On average, analysts anticipate that Oxford Biomedica plc will post -31.0799998 EPS for the current year.

Oxford Biomedica Company Profile

Oxford Biomedica LSE: OXB is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.